BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19831266)

  • 1. Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens: a review.
    Schetters TP; Moubri K; Cooke BM
    J S Afr Vet Assoc; 2009 Jun; 80(2):75-8. PubMed ID: 19831266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN
    Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection.
    Moubri K; Kleuskens J; Van de Crommert J; Scholtes N; Van Kasteren T; Delbecq S; Carcy B; Précigout E; Gorenflot A; Schetters T
    Vet Parasitol; 2018 Jan; 249():21-29. PubMed ID: 29279083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Strydom T; Crafford D; Kleuskens JA; van de Crommert J; Vermeulen AN
    Vet Parasitol; 2007 Mar; 144(1-2):10-9. PubMed ID: 17056181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; van de Crommert J; Krijnen E; Moubri K; Gorenflot A; Vermeulen AN
    Vet Parasitol; 2006 May; 138(1-2):140-6. PubMed ID: 16504401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against large Babesia species from dogs.
    Schetters TP; Kleuskens J; Carcy B; Gorenflot A; Vermeulen A
    Parassitologia; 2007 May; 49 Suppl 1():13-7. PubMed ID: 17691601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against canine babesiosis.
    Schetters T
    Trends Parasitol; 2005 Apr; 21(4):179-84. PubMed ID: 15780840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis.
    Schetters TP; Scholtes NC; Kleuskens JA; Bos HJ
    Parasite Immunol; 1996 Jan; 18(1):1-6. PubMed ID: 9223150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens.
    Schetters TH; Kleuskens J; Scholtes N; Bos HJ
    Parasite Immunol; 1995 Apr; 17(4):215-8. PubMed ID: 7542765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the culture-derived soluble Babesia canis canis antigens derived from the Polish strains of the parasites.
    Adaszek L; Puchalski A; Dec M; Winiarczyk S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(6):399-403. PubMed ID: 23242220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of dogs against Babesia canis infection using antigens from culture supernatants with emphasis on clinical babesiosis.
    Schetters TP; Kleuskens JA; Scholtes NC; Pasman JW; Bos HJ
    Vet Parasitol; 1994 Apr; 52(3-4):219-33. PubMed ID: 8073606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of dogs against Babesia canis infection.
    Schetters TP; Kleuskens JA; Scholtes NC; Pasman JW; Goovaerts D
    Vet Parasitol; 1997 Dec; 73(1-2):35-41. PubMed ID: 9477490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble parasite antigens from Babesia canis do not directly activate the kallikrein system in dogs infected with Babesia canis.
    Finizio AL; Kleuskens JA; Van De Crommert J; Gorenflot A; Carcy B; Schetters TP
    Vet Parasitol; 2011 Mar; 176(2-3):132-8. PubMed ID: 21130577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome number, genome size and polymorphism of European and South African isolates of large Babesia parasites that infect dogs.
    Depoix D; Carcy B; Jumas-Bilak E; Pages M; Precigout E; Schetters TP; Ravel C; Gorenflot A
    Parasitology; 2002 Oct; 125(Pt 4):313-21. PubMed ID: 12403319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against babesiosis using recombinant GPI-anchored proteins.
    Nathaly Wieser S; Schnittger L; Florin-Christensen M; Delbecq S; Schetters T
    Int J Parasitol; 2019 Feb; 49(2):175-181. PubMed ID: 30684517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A field trial evaluation of the prophylactic efficacy of amitraz-impregnated collars against canine babesiosis (Babesia canis rossi) in South Africa.
    Last RD; Hill JM; Matjila PT; Rème CA
    J S Afr Vet Assoc; 2007 Jun; 78(2):63-5. PubMed ID: 17941596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Black-backed jackals (Canis mesomelas) are natural hosts of Babesia rossi, the virulent causative agent of canine babesiosis in sub-Saharan Africa.
    Penzhorn BL; Vorster I; Harrison-White RF; Oosthuizen MC
    Parasit Vectors; 2017 Mar; 10(1):124. PubMed ID: 28285591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The subspecies specificity of Babesia canis].
    Hauschild S; Schein E
    Berl Munch Tierarztl Wochenschr; 1996; 109(6-7):216-9. PubMed ID: 8765536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture.
    Schetters TP; Kleuskens J; Scholtes N; Bos HJ
    Parasite Immunol; 1992 May; 14(3):295-305. PubMed ID: 1625906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Babesia canis isolates, different diseases.
    Schetters TP; Moubri K; Précigout E; Kleuskens J; Scholtes NC; Gorenflot A
    Parasitology; 1997 Nov; 115 ( Pt 5)():485-93. PubMed ID: 9368899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.